Predictors for extremely low serum infliximab trough concentration in patients with crohn's disease

被引：0
|
作者：
Mak, Lung-Yi [1 ]
Tong, Teresa [1 ]
Chen, Equal L. J. [1 ]
Ko, Michael [1 ]
To, Elvis [1 ]
Liu, Kevin S. H. [1 ]
Hung, Ivan F. N. [1 ]
Leung, Wai K. [1 ]
机构：
[1] Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2016年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1568
引用
收藏
页码：169 / 169
页数：1
相关论文
共 50 条
  • [21] Serum Infliximab Trough Levels Above 1.0 Mg/mL Are Required to Obtain Clinical Efficacy in Patients With Crohn's Disease
    Imaeda, Hirotsugu
    Andoh, Akira
    Takahashi, Kenichiro
    Fujimoto, Takehide
    Ban, Hiromitsu
    Bamba, Shigeki
    Fujiyama, Yoshihide
    INFLAMMATORY BOWEL DISEASES, 2012, 18 : S59 - S60
  • [22] Relationship between serum infliximab trough levels and endoscopic activities in patients with Crohn’s disease under scheduled maintenance treatment
    Hirotsugu Imaeda
    Shigeki Bamba
    Kenichiro Takahashi
    Takehide Fujimoto
    Hiromitsu Ban
    Tomoyuki Tsujikawa
    Masaya Sasaki
    Yoshihide Fujiyama
    Akira Andoh
    Journal of Gastroenterology, 2014, 49 : 674 - 682
  • [23] Low Trough Serum Infliximab and Antibodies to Infliximab in Smokers
    Kong, Jee Yuen
    Bundell, Christine
    Pawlik, Janina
    Hollingsworth, Peter
    Forbes, Geoff
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (03) : E35 - E36
  • [24] Higher infliximab trough levels are associated with perianal fistula healing in patients with Crohn's disease
    Yarur, A. J.
    Kanagala, V.
    Stein, D. J.
    Czul, F.
    Quintero, M. A.
    Agrawal, D.
    Patel, A.
    Best, K.
    Fox, C.
    Idstein, K.
    Abreu, M. T.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (07) : 933 - 940
  • [25] Subtherapeutic serum infliximab trough levels and complete mucosal healing are associated with sustained clinical remission after infliximab discontinuation in paediatric Crohn's disease patients
    Kang, B.
    Lee, K.
    Kim, K.
    Lee, J. H.
    Choe, Y. H.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S45 - S46
  • [26] Early serum infliximab trough level and mucosal healing could be predictors for one-year outcome after initiating therapy in Crohn's disease
    Tang, Jian
    Yang, Qingfan
    Huang, Zicheng
    Guo, Huili
    Chao, Kang
    Hu, Pinjin
    Gao, Xiang
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2020, 55 (09) : 1035 - 1040
  • [27] Predictors of response to infliximab in paediatric perianal Crohn's disease
    Dupont-Lucas, C.
    Dabadie, A.
    Alberti, C.
    Ruemmele, F. M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 40 (08) : 917 - 929
  • [28] Predictors of Loss of Response to Infliximab in Pediatric Crohn's Disease
    Selvakumar, Praveen Kumar Conjeevaram
    Szpunar, Susan
    Lyons, Hernando
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S594 - S594
  • [29] Predictors of response to Infliximab in children with luminal Crohn's disease
    Grover, Zubin
    Biron, Rebecca
    Carman, Nicholas
    Lewindon, Peter
    JOURNAL OF CROHNS & COLITIS, 2014, 8 (08): : 739 - 746
  • [30] Higher Postinduction Infliximab Serum Trough Levels Are Associated With Healing of Fistulizing Perianal Crohn's Disease in Children
    El-Matary, Wael
    Walters, Thomas D.
    Huynh, Hien Q.
    deBruyn, Jennifer
    Mack, David R.
    Jacobson, Kevan
    Sherlock, Mary E.
    Church, Peter
    Wine, Eytan
    Carroll, Matthew W.
    Benchimol, Eric I.
    Lawrence, Sally
    Griffiths, Anne M.
    INFLAMMATORY BOWEL DISEASES, 2019, 25 (01) : 150 - 155
12345